-
Sector Analysis
Hepatitis C: Competitive Landscape to 2026
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV), a small enveloped RNA virus. If left untreated, chronic infection can result in fibrosis, cirrhosis, hepatocellular carcinoma, and eventually death. HCV is spread primarily by exposure to infected blood. This report provides an assessment of the pipeline, clinical, and commercial landscape of hepatitis C. Overall, GlobalData expects next-generation direc-acting antiviral (DAA) regimens to drive growth, with opportunities for new entrants residing primarily in emerging markets (Brazil and...
-
Product Insights
Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017" provides an overview of Hematopoietic Stem Cell Transplantation clinical trials scenario. This report provides top line data relating to the clinical trials on Hematopoietic Stem Cell Transplantation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Community Acquired Pneumonia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Community Acquired Pneumonia Global Clinical Trials Review, H1, 2017" provides an overview of Community Acquired Pneumonia clinical trials scenario. This report provides top line data relating to the clinical trials on Community Acquired Pneumonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Community Acquired Pneumonia Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Community Acquired Pneumonia Global Clinical Trials Review, H1, 2019" provides an overview of Community Acquired Pneumonia clinical trials scenario. This report provides top line data relating to the clinical trials on Community Acquired Pneumonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2018" provides an overview of Staphylococcus aureus Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Staphylococcus aureus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Stem Cell Transplantation Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Stem Cell Transplantation Global Clinical Trials Review, H2, 2018" provides an overview of Stem Cell Transplantation clinical trials scenario. This report provides top line data relating to the clinical trials on Stem Cell Transplantation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...